Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension

A Comparison of the Long-Term Effects of Dorzolamide 2% and Brinzolamide 1%, Each Added to Timolol 0.5%, on Retrobulbar Hemodynamics and Intraocular Pressure in Open-Angle Glaucoma Patients

(2009) Antonio Martínez et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Relationship Between Visual Field Severity and Response to Fixed Combination Dorzolamide/Timolol or Timolol Alone

(2009) Kenneth W. Olander et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Literature Review and Meta-Analysis of Topical Carbonic Anhydrase Inhibitors and Ocular Blood Flow

(2009) Brent Siesky et al.   SURVEY OF OPHTHALMOLOGY

A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma

(2008) B Siesky et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: A single-center, 4-year, open-label study

(2008) A MARTINEZ et al.   CLINICAL THERAPEUTICS

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

(2008) Douglas G. Day et al.   CURRENT MEDICAL RESEARCH AND OPINION

Intraocular Pressure Lowering, Change of Antiapoptotic Molecule Expression, and Neuroretinal Changes by Dorzolamide 2%/Timolol 0.5% Combination in a Chronic Ocular Hypertension Rat Model

(2008) Hae Y. Park et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

A Comparison of Visual Field Progression Criteria of 3 Major Glaucoma Trials in Early Manifest Glaucoma Trial Patients

(2008) Anders Heijl et al.   OPHTHALMOLOGY

Intraocular Pressure-Lowering Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Compared with Brinzolamide 1% and Timolol 0.5%

(2008) Martin Kaback et al.   OPHTHALMOLOGY